Pargyline

Pargyline (CAS No.: 555-57-7) is an irreversible monoamine oxidase (MAO) inhibitor that primarily acts on MAO enzymes to regulate the degradation of neurotransmitters. It exhibits selectivity toward MAO enzymes, especially with a lower inhibition constant for MAO-B, indicating higher specificity for MAO-B. As an alkyne-containing click chemistry reagent, Pargyline can form stable covalent bonds with azide-bearing molecules through copper-catalyzed azide-alkyne cycloaddition, which is advantageous for labeling and tracking biomolecules in complex intracellular systems. In research settings, although it has shown antihypertensive and anticancer activities, these applications remain limited to in vitro and preclinical experiments. Pargyline is commonly used at concentrations ranging from low micromolar to nanomolar to explore its ability to modulate cellular responses in different model systems. Therefore, this compound is frequently used in drug discovery and basic research to elucidate enzyme kinetics, signaling pathways, and potential therapeutic targets. The specific concentration used in experiments depends on the objectives and design of the study, emphasizing the need for precise methodological adjustments to identify its biochemical effects.